API Gallery
Yohimbine Hydrochloride API market is projected to grow at a CAGR of 5.8% between 2025 and 2035. This growth is primarily driven by the increasing demand for natural and plant-based therapeutics in both pharmaceutical and nutraceutical sectors.
Zafirlukast API market is projected to grow at a CAGR of 4.8% between 2025 and 2035, primarily driven by the increasing global prevalence of asthma and allergic conditions. Zafirlukast, a leukotriene receptor antagonist, is primarily used in the treatment of chronic asthma, making it a vital component in respiratory therapeutics.
Zanubrutinib API market is projected to grow at a CAGR of 18.6% between 2025 and 2035. The market growth is driven by rising incidences of B-cell malignancies such as chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinemia (WM).
Zastaprazan API market is projected to grow at a CAGR of 7.8% between 2025 and 2035. The market growth is driven by rising prevalence of acid-related gastrointestinal disorders, increasing demand for next-generation proton pump inhibitors (PPIs), and growing pharmaceutical outsourcing activities.
Zavegepant HCl API market is projected to grow at a CAGR of 12% between 2025 and 2035, primarily driven by the increasing prevalence of migraines, rising awareness of effective treatments, and advancements in formulation technologies.
Zavegepant hydrochloride API market is projected to grow at a CAGR of 13.2% between 2025 and 2035, primarily driven by rising demand for innovative migraine treatments. The increasing global prevalence of migraine, especially among women aged 18–44, and the growing adoption of calcitonin gene-related peptide (CGRP) receptor antagonists are key growth drivers.
Zavegepant API market is projected to grow at a CAGR of 10.9% between 2025 and 2035. Zavegepant, an advanced CGRP receptor antagonist, has emerged as a significant player in the migraine treatment market.
Ziconotide Acetate API market is projected to grow at a CAGR of 5.2% between 2025 and 2035. The market is driven by the rising prevalence of chronic and neuropathic pain disorders, particularly among cancer and spinal cord injury patients.
Zidovudine API market is projected to grow at a CAGR of 5.2% between 2025 and 2035. Zidovudine, additionally known as AZT, is a nucleoside reverse transcriptase inhibitor (NRTI) that forms a core component of antiretroviral therapy (ART) for HIV/AIDS.
Zileuton API market is projected to grow at a CAGR of 5.6% between 2025 and 2035, primarily driven by the increasing prevalence of respiratory diseases, particularly asthma and chronic obstructive pulmonary disease (COPD).
Zilpaterol HCl API market is projected to grow at a CAGR of 6.2% between 2025 and 2035, primarily driven by its use in animal feed additives, particularly in the beef cattle industry, where it is used to promote lean muscle growth and improve feed efficiency.
Zilucoplan sodium API market is projected to grow at a CAGR of 10% between 2025 and 2035, primarily driven by the increasing demand for treatments for rare neuromuscular disorders like generalized myasthenia gravis.
Zinc acetate dihydrate API market is projected to grow at a CAGR of 6.2% between 2025 and 2035, primarily driven by its wide applications in pharmaceuticals, nutraceuticals, and veterinary industries.
Zinc monoethyl fumarate API market is projected to grow at a CAGR of 7.2% between 2025 and 2035. The market growth is driven by the increasing preference for non-invasive drug administration methods and the rising prevalence of respiratory disorders such as rhinitis, asthma, and nasal congestion.
Zinc orotate API market is projected to grow at a CAGR of 6.5% between 2025 and 2035. The market growth is driven by rising awareness of zinc’s health benefits, particularly in immunity support, skin care, and nutritional supplements.
Search from 10,000 + API reports
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
